Etanercept is a recombinant human tumor necrosis factor (TNF) receptor fusion protein. It acts as a biologic ...

The Trump administration says it is pulling half a billion dollars from U.S. government-funded research projects to create ...

GSK said the upfront settlement amount will be recorded as other operating income in its financial results as an adjusting item in the income statement in the third quarter of 2025. The 2025 and ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...